Stealth BioTherapeutics (NASDAQ:MITO) is scheduled to be releasing its earnings data before the market opens on Thursday, November 14th. Analysts expect Stealth BioTherapeutics to post earnings of ($0.04) per share for the quarter.
Stealth BioTherapeutics (NASDAQ:MITO) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.04. On average, analysts expect Stealth BioTherapeutics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Shares of MITO traded up $0.32 during midday trading on Tuesday, reaching $6.79. The stock had a trading volume of 7,690 shares, compared to its average volume of 26,118. The firm’s 50 day moving average price is $6.43 and its 200-day moving average price is $10.48. The company has a market capitalization of $226.64 million and a P/E ratio of -4.82. The company has a debt-to-equity ratio of 0.54, a current ratio of 2.13 and a quick ratio of 2.13. Stealth BioTherapeutics has a 52 week low of $4.97 and a 52 week high of $20.99.
About Stealth BioTherapeutics
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate, Elamipretide, has the potential to treat rare genetic and common age-related mitochondrial diseases.
Featured Story: How does a reverse stock split work?
Receive News & Ratings for Stealth BioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stealth BioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.